Pathogenic Escherichia coli

PerkinElmer Launches Industry-Leading Solus One E. coli O157 Pathogen Detection Assay for Beef & Beef Trim Testing

Retrieved on: 
Wednesday, January 27, 2021
Biotechnology, Pharmaceutical, Health, Medical devices, Medical specialties, Escherichia coli, Infectious diseases, Microbiology, Pathogenic bacteria, Escherichia coli O157:H7, Zoonoses, Escherichia, Beef, Pathogenic Escherichia coli, Escherichia coli O104:H21

PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today launched the Solus One E. coli O157 Pathogen Detection Assay for raw ground beef and raw beef trim.

Key Points: 
  • PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today launched the Solus One E. coli O157 Pathogen Detection Assay for raw ground beef and raw beef trim.
  • Escherichia coli (E. coli) is bacteria commonly found as part of normal gut flora of humans and animals.
  • Having robust and accurate E. coli testing capabilities enables food suppliers to take action faster if the pathogen is detected in their facilities.
  • PerkinElmers Solus One E. coli O157 system features a single, 10-hour enrichment, one-step sample preparation and automated workflow to process up to 192 tests per run.

Chicago Indoor Garden is Recalling All Products Containing Red Clover Sprouts

Retrieved on: 
Monday, March 16, 2020
Escherichia coli, Medical specialties, Infectious diseases, Medicine, Shiga toxin, Pathogenic Escherichia coli, Escherichia coli O104:H21

However, eating or drinking food or water contaminated with certain types of E. coli can cause mild to severe gastrointestinal illness.

Key Points: 
  • However, eating or drinking food or water contaminated with certain types of E. coli can cause mild to severe gastrointestinal illness.
  • Some types of pathogenic (illness-causing) E. coli, such as Shiga toxin-producing E. coli (STEC), can be life-threatening.
  • The Red Clover in question has the "Best By" dates between 12/1/19 through 3/12/20 and may have been contaminated with E. coli 0103.
  • In the meantime, we are continuing to grow Red Clover sprouts with seed from a different supplier to ensure this will no longer be problem in the future.

First E. coli Lawsuit filed against Evergreens in Seattle

Retrieved on: 
Tuesday, December 17, 2019
Medical specialties, Medicine, Infectious diseases, Escherichia coli, Escherichia coli O157:H7, Colitis, Diarrhea, Lettuce, Pathogenic Escherichia coli, Enteroinvasive Escherichia coli

coliO157:H7 is a specific member of this family that can cause bloody diarrhea (hemorrhagic colitis) in humans.In the years sinceE.

Key Points: 
  • coliO157:H7 is a specific member of this family that can cause bloody diarrhea (hemorrhagic colitis) in humans.In the years sinceE.
  • coliO157:H7 was first identified as a cause of diarrhea, this bacterium has established a reputation as a significant public health hazard.
  • Our E. coli lawyers have litigated E. coli and HUS cases stemming from outbreaks traced to ground beef, raw milk, lettuce, spinach, sprouts, and other food products.
  • The law firm has brought E. coli lawsuits against such companies as Jack in the Box, Dole, ConAgra, Cargill, andJimmy John's.

ID Genomics' CLoNeT E. coli Assay in Development to Combat Antibiotic Resistant Urinary Tract Infections

Retrieved on: 
Friday, July 19, 2019
Medical specialties, Bacteria, Infectious diseases, Pathogenic bacteria, Bacterial diseases, Urinary tract infection, Antimicrobial resistance, Klebsiella pneumoniae, Staphylococcus aureus, Pathogenic Escherichia coli

SEATTLE, July 19, 2019 /PRNewswire/ --ID Genomics, SPC today announced the completion of its first Pre-Submission meeting with the Food and Drug Administration for the CLoNeT E. coli Assay for Urinary Tract Infections (UTIs).

Key Points: 
  • SEATTLE, July 19, 2019 /PRNewswire/ --ID Genomics, SPC today announced the completion of its first Pre-Submission meeting with the Food and Drug Administration for the CLoNeT E. coli Assay for Urinary Tract Infections (UTIs).
  • "We continue to make great strides in our development plans for the CLoNeT E. coli Assay," said Linda Zuckerman, Ph.D., President and CEO.
  • ID Genomics, SPC is a leading biotech start up focused on development of cutting edge molecular diagnostics to detect and map antibiotic resistance.
  • In addition to the CLoNeT E. coli Assay for UTI, the company is developing diagnostic tools for Staphylococcus aureus, Klebsiella pneumoniae, and other pathogenic bacteria.

FDA Approves AEMCOLO™ (rifamycin), the First Antibiotic Approved for the Treatment of Travelers' Diarrhea in Over a Decade

Retrieved on: 
Monday, November 19, 2018
Medicine, Bacteria, Microbiology, Pathogenic bacteria, Escherichia coli, Diarrhea, Rifamycin, Escherichia, Lipoglycopeptide, Pathogenic Escherichia coli

In October 2017, the FDA granted Qualified Infectious Disease Product (QIDP) and Fast Track designations for AEMCOLO.

Key Points: 
  • In October 2017, the FDA granted Qualified Infectious Disease Product (QIDP) and Fast Track designations for AEMCOLO.
  • AEMCOLO was approved based on data from two randomized, multi-center, controlled Phase 3 clinical trials.
  • AEMCOLO (rifamycin) is an orally administered, minimally absorbed antibiotic approved for the treatment of Travelers' Diarrhea caused by non-invasive strains of Escherichia coli in adults.
  • AEMCOLO is indicated for the treatment of travelers' diarrhea caused by non-invasive strains of Escherichia coli in adults.